| Verelan Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Verelan 240 mg | capsule, extended release | oral | 1.0 each | OTC |
| Verelan 180 mg | capsule, extended release | oral | 1.0 each | OTC |
| Verelan 360 mg | capsule, extended release | oral | 1.0 each | OTC |
Elan Reports Fourth Quarter and Full-Year 2007 Financial Results - WELT ONLINE
... Months Ended December 31 2006 US$m 2007 US$m 2006 US$m 2007 US$m 16.1 20.3 Tricor® 52.1 62.5 11.8 11.2 Skelaxin® 36.5 39.3 8.5 8.0 Verelan® 36.3 28.5 ...
Wed Feb 13 02:16:42 -0500 2008
Elan Reports Fourth Quarter and Full-Year 2007 Financial Results - WELT ONLINE
... Months Ended December 31 2006 US$m 2007 US$m 2006 US$m 2007 US$m 16.1 20.3 Tricor® 52.1 62.5 11.8 11.2 Skelaxin® 36.5 39.3 8.5 8.0 Verelan® 36.3 28.5 ...
Wed Feb 13 02:16:42 -0500 2008
Verapamil for headaches may cause heart problems - Scientific American
Some of the trade names that verapamil is sold under include Calan, Verelan or Covera. Twenty-one patients (19 percent) had an arrhythmia - a disorder of ...
Mon Aug 13 14:11:12 -0400 2007
verapamil hydrochloride - The hydrochloride form of Verapamil, which is a phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04)